...
首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Cannabis Edibles: Blood and Oral Fluid Cannabinoid Pharmacokinetics and Evaluation of Oral Fluid Screening Devices for Predicting Δ9-Tetrahydrocannabinol in Blood and Oral Fluid following Cannabis Brownie Administration
【24h】

Cannabis Edibles: Blood and Oral Fluid Cannabinoid Pharmacokinetics and Evaluation of Oral Fluid Screening Devices for Predicting Δ9-Tetrahydrocannabinol in Blood and Oral Fluid following Cannabis Brownie Administration

机译:大麻食品:大麻布朗尼给药后血液和口服液的大麻药代动力学和口服液筛选装置的评估,用于预测血液和口服液中的Δ9-四氢大麻酚

获取原文
           

摘要

BACKGROUND: Roadside oral fluid (OF) Δ9-tetrahydrocannabinol (THC) detection indicates recent cannabis intake. OF and blood THC pharmacokinetic data are limited and there are no on-site OF screening performance evaluations after controlled edible cannabis.CONTENT: We reviewed OF and blood cannabinoid pharmacokinetics and performance evaluations of the Draeger DrugTest?5000 (DT5000) and Alere? DDS?2 (DDS2) on-site OF screening devices. We also present data from a controlled oral cannabis administration session.SUMMARY: OF THC maximum concentrations (Cmax) were similar in frequent as compared to occasional smokers, while blood THC Cmax were higher in frequent [mean (range) 17.7 (8.0–36.1) μg/L] smokers compared to occasional [8.2 (3.2–14.3) μg/L] smokers. Minor cannabinoids Δ9-tetrahydrocannabivarin and cannabigerol were never detected in blood, and not in OF by 5 or 8 h, respectively, with 0.3 μg/L cutoffs. Recommended performance (analytical sensitivity, specificity, and efficiency) criteria for screening devices of ≥80% are difficult to meet when maximizing true positive (TP) results with confirmation cutoffs below the screening cutoff. TPs were greatest with OF confirmation cutoffs of THC ≥1 and ≥2 μg/L, but analytical sensitivities were 80% due to false negative tests arising from confirmation cutoffs below the DT5000 and DDS2 screening cutoffs; all criteria were 80% with an OF THC ≥5 μg/L cutoff. Performance criteria also were 80% with a blood THC ≥5 μg/L confirmation cutoff; however, positive OF screening results might not confirm due to the time required to collect blood after a crash or police stop. OF confirmation is recommended for roadside OF screening.ClinicalTrials.gov identification number: [NCT02177513][1] [1]: /lookup/external-ref?link_type=CLINTRIALGOV&access_num=NCT02177513&atom=%2Fclinchem%2F63%2F3%2F647.atom
机译:背景:路边口服液(OF)Δ9-四氢大麻酚(THC)检测表明最近有大麻摄入。 OF和血液THC药代动力学数据有限,在食用大麻受控后没有现场OF筛选性能评估。内容:我们回顾了Draeger DrugTest?5000(DT5000)和Alere?的OF和血液大麻素药代动力学以及性能评估。 DDS?2(DDS2)现场OF筛选设备。我们还提供了通过控制性口服大麻给药的数据。摘要:经常吸烟者的THC最大浓度(Cmax)与偶尔吸烟者相似,而经常吸烟者的血液THC Cmax更高[平均值(范围)17.7(8.0-36.1)]与偶尔[8.2(3.2-14.3)微克/升]吸烟者相比。分别在血液中检测不到次要大麻素Δ9-四氢大麻酚和大麻酚,分别在5或8 h时未检测到大麻,在OF中则未检测到,浓度为0.3μg/ L。当最大化真实阳性(TP)结果且确认截止值低于筛选截止值时,难以满足≥80%的筛选设备的推荐性能(分析灵敏度,特异性和效率)标准。当THC≥1和≥2μg/ L的OF截止值时,TPs最高,但由于DT5000和DDS2筛选截止值以下的确认截止值引起的假阴性试验,分析灵敏度<80%。所有标准均> 80%,且THC≥5μg/ L截止。血液THC≥5μg/ L确认截止值时,性能标准也> 80%。但是,由于碰撞或警察停车后需要抽血的时间,因此无法确定OF筛查的阳性结果。建议在路边进行OF筛查时进行OF确认。ClinicalTrials.gov标识号:[NCT02177513] [1] [1]:/ lookup / external-ref?link_type = CLINTRIALGOV&access_num = NCT02177513&atom =%2Fclinchem%2F63%2F3%2F647.atom

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号